title: Eculizumab therapy.
authors.affiliation: Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, Ohio. Electronic address: spero.cataland@osumc.edu.
authors.forename: Spero R
authors.initials: SR
authors.lastname: Cataland
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D002648:Child; D051056:Complement Inactivating Agents / Q000627:therapeutic use*; D015938:Complement Membrane Attack Complex / Q000037:antagonists & inhibitors*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006801:Humans; D057049:Thrombotic Microangiopathies / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D051056:Complement Inactivating Agents; D015938:Complement Membrane Attack Complex; C481642:eculizumab